Cell and Gene Therapy in Canada - Insights Magazine Back Bay in the NewsBack Bay Life Science AdvisorsJune 2, 2022Cell Therapy, Drug Development, Biopharma, Funding, Partnering, Canada
From Drug Target Inhibition to Degradation: a TACtical Strategy - Nature Biopharma Dealmakers Back Bay in the NewsBack Bay Life Science AdvisorsJune 2, 2022IPOs, VC, Drug Development, Investment Banking
Back Bay Associate Named Consulting Magazine’s Rising Star for Excellence in Financial Consulting Back Bay in the News, Awards and RankingsInvestment Banking TeamFebruary 28, 2022Investment Banking, Consulting Awards
Med Device Online: An Overview of The Remote Patient Monitoring Device & Telehealth Market Back Bay in the NewsBack Bay Life Science AdvisorsNovember 1, 2021Medtech investment, Remote Patient Monitoring, Investment, Life Science Deals
Back Bay in Cell & Gene: The Next Decade In Gene Therapy Innovation, Six Critical Questions (And Answers) Back Bay in the NewsBack Bay Life Science AdvisorsMay 21, 2021Gene Therapy, Vector Technology, Biotech Investment, Rare Disease, Drug Pricing
STAT News: Investment in Antimicrobials Was Up in 2020, But Much Work Remains Back Bay in the NewsBack Bay Life Science AdvisorsApril 28, 2021Anti-Infectives, Vaccines, Funding, Emerging BioPharma, Commercial Development
CELL & GENE: Immunotherapy For Glioblastoma: A Path Forward Media Coverage, Back Bay in the NewsBack Bay Life Science AdvisorsAugust 11, 2020Gene Therapy, IO
Saving Antibiotic Drug Development Back Bay in the NewsBack Bay Life Science AdvisorsJune 29, 2020Anti-Infectives, Anti-Microbials, Drug Development
CELL & GENE: Looking Beyond Alpha-Beta Cells for Cell Therapies Back Bay in the NewsBack Bay Life Science AdvisorsMarch 27, 2020Gene Therapy
STAT NEWS: Microbiome Drug Development a Rapidly Evolving Field Insights, Back Bay in the News, Life Science MediaBack Bay Life Science AdvisorsNovember 13, 2019Microbiome, Drug Development
STAT: Early Price Setting, Other Market Access Planning is Key for Early-Stage Drug, Device Companies Back Bay in the News, Life Science MediaChristopher Leo, PhD October 29, 2019Drug Pricing, Market Access, Emerging BioPharma, Emerging Companies
